Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-28.10	13.76	19.13
Graham Fair Price	134.31	36205.21	15451.64
PEG	97.88	< 0.005	-0.22
Price/Book	-13.63	0.33	0.39
Price/Cash Flow	-9.05	6.72	7.39
Prices/Earnings	-83.51	2.94	-17.85
Price/Sales	-14.19	0.17	0.19
Price/FCF	-9.05	6.72	7.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	11.88	0.23	0.21
Operating Margin	82.56	0.08	0.04
ROA	415.58	< 0.005	< 0.005
ROE	< 0.005	0.03	423.88
ROIC	< 0.005	0.03	361.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.06	0.02	153.28
Dividends QOQ	< 0.005	-0.62	-36404.99
EBIT QOQ	-0.24	0.88	263.02
EPS QOQ	-0.82	6.36	676.07
FCF QOQ	0.75	-0.03	-96.52
Revenue QOQ	0.01	0.03	134.50
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	32.73	37.60	14.85
Days Sales Outstanding (DSO)	34.74	31.57	-9.12
Inventory Turnover	2.75	2.39	-12.93
Debt/Capitalization	0.73	0.74	1.61
Quick Ratio	0.34	0.38	8.81
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	44338.61	45390.05	2.37
Cash	39153.88	51688.20	32.01
Capex	-10594.80	-2526.57	76.15
Free Cash Flow	2313.20	2248.64	-2.79
Revenue	88611.10	91303.35	3.04
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.55	0.60	8.87
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	17.17	12.53	-27.02
Naive Interpretation	Member

06 - Financial Health · Bad

Rating